A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau disease

Cathy D Vocke,Christopher J Ricketts,Svetlana Pack,Mark Raffeld,Stephen Hewitt,Alexandra P Lebensohn,Lidenys O'Brien,Rabindra Gautam,Krista Reynolds,Laura S Schmidt,Kristin Choo,Alex Kenigsberg,Sandeep Gurram,Emily Y Chew,Naris Nilubol,Prashant Chittaboina,Maria J Merino,Mark W Ball,W Marston Linehan
DOI: https://doi.org/10.1136/jmg-2024-110202
2024-10-23
Abstract:von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the VHL tumour suppressor gene. VHL patients are at increased risk of developing multiple benign and malignant tumours. Current CLIA-based genetic tests demonstrate a very high detection rate of germline VHL variants in patients with clinical manifestations of VHL. In this report, we describe a large family with canonical VHL manifestations, for which no germline alteration had been detected by conventional germline testing. We identified a novel 291 kb chromosomal inversion involving chromosome 3p in affected family members. This inversion disrupts the VHL gene between exon 2 and exon 3 and is thereby responsible for the disease observed in this family.
What problem does this paper attempt to address?